Lipid levels among African and Middle-Eastern Bedouin populations

Medical Science Monitor

Volumn 14, Issue 6, 2008, Pages

  Dreiher, Jacob ^a   Cohen, Arnon D ^a   Weitzman, Shimon ^a   Sharf, Amir ^a   Shvartzman, Pesach ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

Ancestry; Dyslipidemia; Ethnicity; Hyperlipidemia

Indexed keywords

ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; ORAL ANTIDIABETIC AGENT; TRIACYLGLYCEROL;

ADULT; AFRICA; AGED; ARAB; ARTICLE; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; DIABETES MELLITUS; DYSLIPIDEMIA; ETHNIC GROUP; FEMALE; HUMAN; HYPERTENSION; ISRAEL; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MIDDLE EAST; MULTIPLE LINEAR REGRESSION ANALYSIS; OBESITY; PREVALENCE; RACE DIFFERENCE; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; AFRICA; ARABS; CHOLESTEROL, HDL; CHOLESTEROL, LDL; FEMALE; HUMANS; LIPIDS; MALE; MIDDLE EAST; MULTIVARIATE ANALYSIS; TRIGLYCERIDES;

EID: 46449112769     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Ferdinand KC: Hypertension in minority populations. J Clin Hypertens, 2006; 8: 365-68
2. Ferdinand KC, Clark LT: The epidemic of diabetes mellitus and the metabolic syndrome in African Americans. Rev Cardiovasc Med, 2004; 5(Suppl.3): S28-33
3. Jones DW, Chambless LE, Folsom AR et al: Risk factors for coronary heart disease in African Americans: The Atherosclerosis Risk in Communities study, 1987-1997. Arch Intern Med, 2002; 162: 2565-71
4. Khera A, McGuire DK, Murphy SA et al: Race and gender differences in C-reactive protein levels. J Am Coll Cardiol, 2005; 46: 464-69
5. Okosun IS, Liao Y, Rotimi CN et al: Abdominal adiposity and clustering of multiple metabolic syndrome in White, Black and Hispanic Americans. Ann Epidemiol, 2000; 10: 263-70
6. Goff DC, Bertoni AG, Kramer H et al: Dyslipidemia prevalence, treatment, and control in the Multi-Ethnic Study of Atherosclerosis (MESA): gender, ethnicity and coronary artery calcium. Circulation, 2006; 113: 647-56
7. Albert MA, Torres J, Glynn RJ, Ridker PM: Perspective on selected issues in cardiovascular disease research with a focus on Black American. Circulation, 2004; 100: e7-12
8. Haffner SM, D'Agostino R Jr, Goff D et al: LDL size in African Americans, Hispanics, and non-Hispanic whites: the Insulin Resistance Atherosclerosis Study Arterioscler Thromb Vasc Biol, 1999; 19: 2234-40
9. Fraser D, Weitzman S, Blondheim S et al: The prevalence of cardiovascular risk factors among male Bedouins: a population in transition. Eur J Epidemiol, 1990; 6: 273-78
10. Nitzan-Kalusky D, Green M: [MABAT: First Israeli National Health and Nutrition Survey, 1999-2001. Part 1: General Findings] (in Hebrew). Israel Center for Disease Control, Ministry of Health, Publication No. 225, 2003. Available from URL: wwwhealth.gov.il/download/pages/meyuhad.pdf, Accessed July 28, 2007
11. Abdul-Rahim HF, Husseini A, Bjertness E et al: The metabolic syndrome in the West Bank population: An urban-rural comparison. Diabetes Care, 2001; 24: 275-79
12. Al-Lawati JA, Mohammed AJ, Al-Hinai HQ, Jousilahti P: Prevalence of the metabolic syndrome among Omani adults. Diabetes Care, 2003; 26: 1781-85
13. Abou-Rbiah Y, Weitzman S: Diabetes among Bedouins in the Negev the transition from a rare to a highly prevalent condition. Isr Med Assoc J, 2002; 4: 687-89
14. Cohen AD, Gefen K, Ozer A et al: Diabetes control in the Bedouin population in southern Israel. Med Sci Monit, 2005; 11(8): CR376-80
15. Tamir O, Peleg R, Dreiher J et al: Cardiovascular risk factors in the Bedouin population: Management and compliance. Isr Med Assoc J, 2007; 9: 652-56
16. Richards M, Rengo C, Cruciani F et al: Extensive female-mediated gene flow from sub-Saharan Africa into Near Eastern Arab populations. Am J Hum Genet, 2003; 72: 1058-64
17. Luis JR, Rowold DJ, Regueiro M et al: The Levant versus the Horn of Africa: Evidence for bidirectional corridors of human migrations. Am J Hum Genet, 2004; 74: 532-44
18. NCEP. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) - Final Report. NIH publication No. 02-5215, 2002
19. Howard BV, Criqui MH, Curb JD et al: Risk factor clustering in the Insulin Resistance Syndrome and its relationship to cardiovascular disease in postmenopausal White, Black, Hispanic and Asian/Pacific Islander women. Metabolism, 2003; 52: 362-71
20. Mensah GA, Mokdad AH, Ford ES et al: State of disparities in cardiovascular health in the Unites States. Circulation, 2005; 111: 1233-41
21. LaRosa JC, Brown CD: Cardiovascular risk factors in minorities. Am J Med, 2005; 118: 1314-22
22. Keil JE, Sutherland SE, Knapp RG et al: Mortality rates and risk factors for coronary disease in Black as compared with White men and women. New Engl J Med, 1993; 329: 73-78
23. Thomas AJ, Eberly LE, Davey Smith G et al: Race/ethnicity, income, major risk factors and cardiovascular disease mortality. Am J Public Health, 2005; 95: 1417-23
24. Cooper RS, Rotimi CN, Kaufman JS et al: Prevalence of NIDDM among populations of the African Diaspora. Diabetes Care, 1997; 20: 343-48
25. Salas A, Carracedo A, Richards M, Macaulay V: Charting the ancestry of African Americans. Am J Hum Genet, 2005; 77: 676-80
26. Pearce N: Effect measures in prevalence studies. Env Health Pers, 2004; 112: 1047-50
27. nd ed, Lippincott-Raven, 1998; 42-45, 76-77
28. Szklo M, Nieto EJ: Epidemiology Beyond the Basics, Gaithersburg, Maryland, Aspen Publishers, Inc., 2000; 85-87, 155-60
29. Potts JL, Thomas J: Traditional coronary risk factors in African Americans. Am J Med Sci, 1999; 317: 189-92
30. Romeo S, Pennacchio LA, Fu Y et al: Population-based resequencing of ANGPTL4 uncovers variations that reduce triglyderides and increase HDL. Nat Genet, 2007; 39: 513-16
31. Cohen JC, Boerwinkle E, Mosley TH Jr, Hobbs HH: Sequence variations in PCSK9, low LDL, and protection against coronary heart disease. N Engl J Med, 2006; 354: 1310-12
32. Hallman DM, Srinivasan SR, Chen W et al: Relation of PCSK9 mutations to serum low-density lipoprotein cholesterol in childhood and adulthood (from the Bogalusa heart Study). Am J Cardiol, 2007; 100: 69-72
33. Hooper AJ, Marais AD, Tanyanyiwa DM, Burnett JR: The C679X mutation in PCSK9 is present and lowers blood cholesterol in a Southern African poulation. Atherosclerosis, 2007; 193: 445-48
34. Karter AJ: Race and ethnicity: Vital constructs for diabetes research. Diabetes Care, 2003; 26: 2189-93
35. Kalra L, Rambaran C, Iveson E et al: The role of inheritance and environment in predisposition to vascular disease in people of African descent. J Am Coll Cardiol, 2006; 47: 1126-33